• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Mavens on TheStreet
    • Biotech Maven
    • EconoMonitor
    • ETF Focus
    • FX@TheStreet with Cory Mitchell - Forex Trade Ideas
    • John Wall Street - Sports Business
    • Mish Talk - Global Economic Trends
    • Phil Davis - The Progressive Investor
    • Random Roger - ETF and Retirement
    • Stan The Annuity Man
    • Bull Market Fantasy with Jim Cramer
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Novus Therapeutics Announces Exercise Of Warrants For $4.7 Million Gross Proceeds

  • By Business Wire
  • Jan 10, 2020 5:19 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2020 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.